South Africa Neurology Devices Market Analysis by Mordor Intelligence
The South Africa Neurology Devices Market size is projected to expand from USD 92.11 million in 2026 and USD 98.94 million in 2027 to USD 141.45 million by 2032, registering a CAGR of 7.41% between 2027 and 2032.
According to the World Population Aging 2019 report, in South Africa, the population aged 65 years or over in 2019 was 3.171 million (5.4%), and this number is projected to reach 4.404 million (6.7%) in 2030. This is expected to consistently increase the dementia patient population which boost the interest of existing players to invest more in this country.
Thus, owing to the above factors, the market is expected to show significant growth over the forecast period.
Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.
South Africa Neurology Devices Market Trends and Insights
Sacral Nerve Stimulation Devices is the Segment under Neurostimulation Devices that is Expected to Grow Fastest during the Forecast Period
Sacral nerve stimulation devices offer a therapeutic option for patients who do not achieve adequate symptom relief through drug therapy or other medications. The treatment involves implanting a small device that delivers controlled electrical impulses to targeted sacral nerves in the lower back. These impulses help regulate nerve signals associated with bladder function, making the therapy effective for managing bladder disorders, including overactive bladder. The increasing prevalence of overactive bladder and the growing need for minimally invasive treatment options are expected to support segment growth during the forecast period. In addition, advancements in implantable neuromodulation technologies may further improve treatment outcomes and the adoption of sacral nerve stimulation devices.
Sacral nerve stimulation devices are an effective and safe treatment for patients suffering from fecal and urinary dysfunction. Increasing demand for minimally invasive therapy, rising prevalence of urinary bladder diseases, and technological advancements such as the introduction of novel coatings and engineering strategies are the main factors driving the growth of the market.
In South Africa, Medtronic Plc offers "The InterStim II System" the neurostimulator for bladder and bowel control which delivers sustained improvements in quality of life for people with overactive bladder (OAB), non-obstructive urinary retention, and chronic fecal incontinence (FI).
Competitive Landscape
The South Africa Neurology Devices Market is fragmented competitive. There are market participants involved in R&D for the development of advanced stimulation and neuromodulation techniques with minimally invasive procedures that are more preferable to the patients. Furthermore, many private companies are showing great interest in developing novel neurological devices to earn huge profits. In the coming years few other players are expected to enter into the market.
South Africa Neurology Devices Industry Leaders
-
B. Braun Melsungen AG
-
Stryker Corporation
-
Medtronic PLC
-
Abbott Laboratories
-
Johnson and Johnson
- *Disclaimer: Major Players sorted in no particular order
South Africa Neurology Devices Market Report Scope
As per the scope of the report, neurological devices are medical devices that help to diagnose, prevent, and treat a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson's disease, major depression, and traumatic brain injury. The growth of neurological devices is being driven through an emphasis on developing superior neuromodulation and neurostimulation techniques, leveraging minimally invasive procedures that benefit patients. The South Africa Neurology Devices Market is segmented by type of device (Cerebrospinal Fluid Management Device, Interventional Neurology Device, Neurosurgery Device, Neurostimulation Device, and Other Type of Devices).
| Cerebrospinal Fluid Management Devices | |
| Interventional Neurology Devices | Interventional/Surgical Simulators |
| Neurothrombectomy Devices | |
| Carotid Artery Stents | |
| Others | |
| Neurosurgery Devices | Neuroendoscopes |
| Stereotactic Systems | |
| Other Neurosurgery Devices | |
| Neurostimulation Devices | Spinal Cord Stimulation Devices |
| Deep Brain Stimulation Devices | |
| Sacral Nerve Stimulation Devices | |
| Other Neurostimulation Devices | |
| Other Types of Devices |
| By Type of Device | Cerebrospinal Fluid Management Devices | |
| Interventional Neurology Devices | Interventional/Surgical Simulators | |
| Neurothrombectomy Devices | ||
| Carotid Artery Stents | ||
| Others | ||
| Neurosurgery Devices | Neuroendoscopes | |
| Stereotactic Systems | ||
| Other Neurosurgery Devices | ||
| Neurostimulation Devices | Spinal Cord Stimulation Devices | |
| Deep Brain Stimulation Devices | ||
| Sacral Nerve Stimulation Devices | ||
| Other Neurostimulation Devices | ||
| Other Types of Devices | ||
Key Questions Answered in the Report
What is the current South Africa Neurology Devices Market size?
The South Africa Neurology Devices Market is projected to register a CAGR of 7.41% during the forecast period (2027-2032)
Who are the key players in South Africa Neurology Devices Market?
B. Braun Melsungen AG, Stryker Corporation, Medtronic PLC, Abbott Laboratories and Johnson and Johnson are the major companies operating in the South Africa Neurology Devices Market.
What years does this South Africa Neurology Devices Market cover?
The report covers the South Africa Neurology Devices Market historical market size for years: 2021, 2022, 2023, 2024, and 2025. The report also forecasts the South Africa Neurology Devices Market size for years: 2027, 2028, 2029, 2030, 2031, and 2032.